| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1552851 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP4F13 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYP4F6 mRNA | CTD | PMID:16174780 |
| 17beta-estradiol | decreases expression | ISO | RGD:1349362 | 6480464 | Estradiol results in decreased expression of CYP4F3 mRNA | CTD | PMID:17982697 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1349362 | 6480464 | [Parathion co-treated with Estradiol] results in increased expression of CYP4F3 mRNA | CTD | PMID:17982697 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1552851 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP4F13 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1552851 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP4F13 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP4F6 mRNA | CTD | PMID:21215274 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1552851 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CYP4F13 mRNA | CTD | PMID:20188158 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of CYP4F6 mRNA | CTD | PMID:11328961 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| aflatoxin B1 | decreases expression | ISO | RGD:1552851 | 6480464 | Aflatoxin B1 results in decreased expression of CYP4F13 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1349362 | 6480464 | Tretinoin results in increased expression of CYP4F3 mRNA | CTD | PMID:17218384 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1349362 | 6480464 | Tretinoin results in increased expression of CYP4F3 protein | CTD | PMID:20036648 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYP4F6 mRNA | CTD | PMID:16483693 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| benzene | increases expression | ISO | RGD:1349362 | 6480464 | Benzene results in increased expression of CYP4F3 protein; more ... | CTD | PMID:20036648 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of CYP4F6 promoter | CTD | PMID:22457795 |
| carbamazepine | increases expression | ISO | RGD:1349362 | 6480464 | Carbamazepine results in increased expression of CYP4F3 mRNA | CTD | PMID:17112801 |
| clofibrate | decreases expression | ISO | RGD:1552851 | 6480464 | Clofibrate results in decreased expression of CYP4F13 mRNA | CTD | PMID:17585979 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP4F6 mRNA | CTD | PMID:11328961 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of CYP4F6 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1349362 | 6480464 | Copper Sulfate results in decreased expression of CYP4F3 mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | decreases expression | ISO | RGD:1349362 | 6480464 | Asbestos, Crocidolite results in decreased expression of CYP4F3 mRNA | CTD | PMID:18687144 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP4F6 mRNA | CTD | PMID:11328961 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CYP4F6 mRNA | CTD | PMID:21266533 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CYP4F6 mRNA | CTD | PMID:18299717 |
| isotretinoin | decreases expression | ISO | RGD:1349362 | 6480464 | Isotretinoin results in decreased expression of CYP4F3 mRNA | CTD | PMID:20436886 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| lithocholic acid | multiple interactions | ISO | RGD:1552851 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of CYP4F13 mRNA | CTD | PMID:20359477 |
| lithocholic acid | decreases expression | ISO | RGD:1552851 | 6480464 | Lithocholic Acid results in decreased expression of CYP4F13 mRNA | CTD | PMID:20359477 |
| methotrexate | increases expression | ISO | RGD:1349362 | 6480464 | Methotrexate results in increased expression of CYP4F3 mRNA | CTD | PMID:17400583 |
| methylphenidate | decreases expression | ISO | RGD:1552851 | 6480464 | Methylphenidate results in decreased expression of CYP4F13 mRNA | CTD | PMID:22470460 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| paracetamol | affects expression | ISO | RGD:1552851 | 6480464 | Acetaminophen affects the expression of CYP4F13 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1349362 | 6480464 | Acetaminophen results in increased expression of CYP4F3 mRNA | CTD | PMID:22230336 |
| parathion | multiple interactions | ISO | RGD:1349362 | 6480464 | [Parathion co-treated with Estradiol] results in increased expression of CYP4F3 mRNA | CTD | PMID:17982697 |
| parathion | increases expression | ISO | RGD:1349362 | 6480464 | Parathion results in increased expression of CYP4F3 mRNA | CTD | PMID:17982697 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CYP4F6 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CYP4F6 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:1349362 | 6480464 | Phenobarbital affects the expression of CYP4F3 mRNA | CTD | PMID:19084549 |
| phenol | increases expression | ISO | RGD:1349362 | 6480464 | Phenol results in increased expression of CYP4F3 mRNA; more ... | CTD | PMID:20036648 |
| pirinixic acid | increases expression | ISO | RGD:1552851 | 6480464 | pirinixic acid results in increased expression of CYP4F13 mRNA | CTD | PMID:17426115 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CYP4F6 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:1552851 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of CYP4F13 mRNA | CTD | PMID:20359477 |
| thapsigargin | decreases expression | ISO | RGD:1349362 | 6480464 | Thapsigargin results in decreased expression of CYP4F3 mRNA | CTD | PMID:19442820 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of CYP4F6 mRNA | CTD | PMID:19483382 |